Capital Increase to finance bionic vision
Pixium Vision is a small medtech that develops systems to allow the blind to partially recover their sight. It’s raising 10 million euros with capital increase.
Pixium Vision is a small medtech that develops systems to allow the blind to partially recover their sight. It’s raising 10 million euros with capital increase.
Millions of people are slowly losing their vision to diseases of the retina, such as age-related macular degeneration. Now, a device more than a decade in the making may help some of them see again.
In the future, more efficient systems could not only replace the sight of people with total blindness but also improve the visual perception of visually impaired people.
At the rate of a patient per month, the clinical trial ” is making good progress in France ” comments on an analyst. The share is in sharp increase